NCT06346834View on ClinicalTrials.gov

Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

September 6, 2024

Study Completion Date

December 6, 2024

Conditions

Poliomyelitis

Interventions

BIOLOGICAL

sIPV

One dose of the experimental/control vaccine will be administered to 4-month-old infants who have already received two doses of sIPV from Beijing Institute of Biological Products Co., LTD.

Trial Locations (1)

Unknown

Disease Control and Prevention Center, Xiaonan District, Xiaogan City, Xiaogan

All Listed Sponsors

lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT06346834 - Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers | Biotech Hunter | Biotech Hunter